PASSAGE BIO, INC. Payments to Acquire Machinery and Equipment
PASSAGE BIO, INC. (PASG) reported Payments to Acquire Machinery and Equipment of $34.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMachineryAndEquipment · last filed 2025-03-04
- PASSAGE BIO, INC. payments to acquire machinery and equipment for the quarter ending 2024-12-31 was $14.00K, a 7.69% increase year-over-year.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for the quarter ending 2023-12-31 was $13.00K, a 97.26% decline year-over-year.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for the quarter ending 2023-09-30 was $4.00K, a 98.36% decline year-over-year.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for the quarter ending 2023-06-30 was $103.00K, a 87.61% decline year-over-year.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for fiscal 2024 was $34.00K, a 76.71% decline from fiscal 2023.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for fiscal 2023 was $146.00K, a 93.58% decline from fiscal 2022.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for fiscal 2022 was $2.27M, a 87.11% decline from fiscal 2021.
- PASSAGE BIO, INC. payments to acquire machinery and equipment for fiscal 2021 was $17.64M, a 1439.44% increase from fiscal 2020.
| Period end | Payments to Acquire Machinery and Equipment 3 month | Payments to Acquire Machinery and Equipment 6 month | Payments to Acquire Machinery and Equipment 9 month | Payments to Acquire Machinery and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $34.00K 10-K · filed 2025-03-04 | ||
| 2024-09-30 | $20.00K 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $17.00K derived: sum of 2 quarters · filed 2025-03-04 | $120.00K derived: sum of 3 quarters · filed 2025-03-04 | $146.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $107.00K derived: sum of 2 quarters · filed 2024-11-13 | $133.00K 10-Q · filed 2024-11-13 | $607.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $129.00K 10-Q · filed 2024-08-08 | $603.00K derived: sum of 3 quarters · filed 2024-08-08 | $847.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $26.00K 10-Q · filed 2024-05-14 | $500.00K derived: sum of 2 quarters · filed 2024-05-14 | $744.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.57M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $718.00K derived: sum of 2 quarters · filed 2024-03-04 | $1.55M derived: sum of 3 quarters · filed 2024-03-04 | $2.27M 10-K · filed 2024-03-04 |
| 2022-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.07M derived: sum of 2 quarters · filed 2023-11-13 | $1.80M 10-Q · filed 2023-11-13 | $8.62M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.56M 10-Q · filed 2023-08-07 | $8.38M derived: sum of 3 quarters · filed 2023-08-07 | $14.39M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $725.00K 10-Q · filed 2023-05-11 | $7.54M derived: sum of 2 quarters · filed 2023-05-11 | $13.56M derived: sum of 3 quarters · filed 2023-05-11 | $17.57M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $12.83M derived: sum of 2 quarters · filed 2023-03-06 | $16.84M derived: sum of 3 quarters · filed 2023-03-06 | $17.64M 10-K · filed 2023-03-06 |
| 2021-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $10.02M derived: sum of 2 quarters · filed 2022-11-10 | $10.82M 10-Q · filed 2022-11-10 | $11.63M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.81M 10-Q · filed 2022-08-04 | $5.62M derived: sum of 3 quarters · filed 2022-08-04 | $5.76M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $801.00K 10-Q · filed 2022-05-16 | $1.60M derived: sum of 2 quarters · filed 2022-05-16 | $1.75M derived: sum of 3 quarters · filed 2022-05-16 | $1.85M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $953.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.05M derived: sum of 3 quarters · filed 2022-03-03 | $1.15M 10-K · filed 2022-03-03 |
| 2020-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $243.00K derived: sum of 2 quarters · filed 2021-11-04 | $342.00K 10-Q · filed 2021-11-04 | $385.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $193.00K 10-Q · filed 2021-08-05 | $236.00K derived: sum of 3 quarters · filed 2021-08-05 | $345.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $99.00K 10-Q · filed 2021-05-05 | $142.00K derived: sum of 2 quarters · filed 2021-05-05 | $251.00K derived: sum of 3 quarters · filed 2021-05-05 | $408.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $152.00K derived: sum of 2 quarters · filed 2021-03-03 | $309.00K derived: sum of 3 quarters · filed 2021-03-03 | $1.19M 10-K · filed 2021-03-03 |
| 2019-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $266.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.15M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.04M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $884.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |